Transfusion management of patients treated with monoclonal antibody (MAb) therapies that interfere with immunohaematology testing

Home/ Guidelines/ Transfusion management of patients treated with monoclonal antibody (MAb) therapies that interfere with immunohaematology testing
Guideline
Authored by ANZSBT
Last updated: 11 June 2025
View amendments
FINAL-ANZSBT-Therapeutic-Monoclonal-Antibodies-Published-20211201
Size: 221 KB
Download

Foreword

Addendum to ANZSBT Guidelines for Transfusion and Immunohaematology Laboratory Practice (revised 1st edition; January 2020), December 2021

Scope

This addendum is intended to guide laboratories in provision of compatible blood for transfusion. It applies to Section 2 Pretransfusion testing, and Section 3 Selecting Blood Products for Transfusion, Section 4 Use of blood products in specific clinical situations of the guidelines.

Download

FINAL-ANZSBT-Therapeutic-Monoclonal-Antibodies-Published-20211201
Size: 221 KB
Download

Share: